In8bio, Inc. (INAB)

CIK 1740279 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for In8bio, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G/A0000935836-26-000398
Aug 7, 2026S-80001193125-26-338511
Aug 6, 202610-Q0001193125-26-338012
Aug 6, 20268-K0001193125-26-337944
Jun 1, 20268-K0001193125-26-249684
Jun 1, 2026424B50001193125-26-249564
May 29, 2026SCHEDULE 13D/A0001682638-26-000008
May 29, 202640001682638-26-000006
May 19, 2026EFFECT9999999995-26-001697
May 18, 2026S-3/A0001193125-26-229132
May 12, 202640001898521-26-000004
May 12, 202640001830914-26-000004
May 12, 202640001975028-26-000002
May 12, 202640001839156-26-000002
May 12, 202640001853815-26-000002
May 12, 202640001434099-26-000002
May 12, 202640001830059-26-000004
May 12, 202640001682638-26-000004
May 12, 202640001874384-26-000004
May 7, 2026S-8 POS0001193125-26-212444
May 7, 2026S-8 POS0001193125-26-212454
May 7, 2026S-80001193125-26-212434
May 7, 2026S-8 POS0001193125-26-212441
May 7, 202610-Q0001193125-26-212135
May 7, 20268-K0001193125-26-212128